Literature DB >> 25401944

Myeloid-derived suppressor cells: paradoxical roles in infection and immunity.

Jun Dai1, Mohamed El Gazzar, Guang Y Li, Jonathan P Moorman, Zhi Q Yao.   

Abstract

Myeloid-derived suppressor cells (MDSCs) are a heterogeneous population of immature suppressor cells that are generated due to aberrant myelopoiesis under pathological conditions. Although MDSCs have been recognized for more than 20 years under the guise of different monikers, these particular populations of myeloid cells gained more attention recently due to their immunosuppressive properties, which halt host immune responses to growing cancers or overwhelming infections. While MDSCs may contribute to immune homeostasis after infection or tissue injury by limiting excessive inflammatory processes, their expansion may be at the expense of pathogen elimination and thus may lead to disease persistence. Therefore, MDSCs may be either damaging or obliging to the host by attenuating, for example, antitumor or anti-infectious immune responses. In this review, we recapitulate the biological and immunological aspects of MDSCs, including their generation, distribution, trafficking and the factors involved in their activation, expansion, suppressive functions, and interplay between MDSCs and regulatory T cells, with a focus on the perspectives of infection and inflammation.
© 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2014        PMID: 25401944      PMCID: PMC4348209          DOI: 10.1159/000368233

Source DB:  PubMed          Journal:  J Innate Immun        ISSN: 1662-811X            Impact factor:   7.349


  102 in total

1.  IL-12 suppression during experimental endotoxin tolerance: dendritic cell loss and macrophage hyporesponsiveness.

Authors:  M Wysocka; S Robertson; H Riemann; J Caamano; C Hunter; A Mackiewicz; L J Montaner; G Trinchieri; C L Karp
Journal:  J Immunol       Date:  2001-06-15       Impact factor: 5.422

2.  Immune stimulatory receptor CD40 is required for T-cell suppression and T regulatory cell activation mediated by myeloid-derived suppressor cells in cancer.

Authors:  Ping-Ying Pan; Ge Ma; Kaare J Weber; Junko Ozao-Choy; George Wang; Bingjiao Yin; Celia M Divino; Shu-Hsia Chen
Journal:  Cancer Res       Date:  2009-12-08       Impact factor: 12.701

3.  Induction of regulatory T cells by macrophages is dependent on production of reactive oxygen species.

Authors:  Marina D Kraaij; Nigel D L Savage; Sandra W van der Kooij; Karin Koekkoek; Jun Wang; J Merlijn van den Berg; Tom H M Ottenhoff; Taco W Kuijpers; Rikard Holmdahl; Cees van Kooten; Kyra A Gelderman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-22       Impact factor: 11.205

4.  All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients.

Authors:  Noweeda Mirza; Mayer Fishman; Ingo Fricke; Mary Dunn; Anthony M Neuger; Timothy J Frost; Richard M Lush; Scott Antonia; Dmitry I Gabrilovich
Journal:  Cancer Res       Date:  2006-09-15       Impact factor: 12.701

5.  Reactive oxygen species and 12/15-lipoxygenase contribute to the antiproliferative capacity of alternatively activated myeloid cells elicited during helminth infection.

Authors:  Lea Brys; Alain Beschin; Geert Raes; Gholamreza Hassanzadeh Ghassabeh; Wim Noël; Jef Brandt; Frank Brombacher; Patrick De Baetselier
Journal:  J Immunol       Date:  2005-05-15       Impact factor: 5.422

6.  Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine.

Authors:  Paola Filipazzi; Roberta Valenti; Veronica Huber; Lorenzo Pilla; Paola Canese; Manuela Iero; Chiara Castelli; Luigi Mariani; Giorgio Parmiani; Licia Rivoltini
Journal:  J Clin Oncol       Date:  2007-06-20       Impact factor: 44.544

7.  High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells.

Authors:  Paolo Serafini; Rebecca Carbley; Kimberly A Noonan; Gladys Tan; Vincenzo Bronte; Ivan Borrello
Journal:  Cancer Res       Date:  2004-09-01       Impact factor: 12.701

8.  CD11b+Ly-6C(hi) suppressive monocytes in experimental autoimmune encephalomyelitis.

Authors:  Bing Zhu; Yoshio Bando; Sheng Xiao; Kaiyong Yang; Ana C Anderson; Vijay K Kuchroo; Samia J Khoury
Journal:  J Immunol       Date:  2007-10-15       Impact factor: 5.422

9.  Lung cancer patients' CD4(+) T cells are activated in vitro by MHC II cell-based vaccines despite the presence of myeloid-derived suppressor cells.

Authors:  Minu K Srivastava; Jacobus J Bosch; James A Thompson; Bruce R Ksander; Martin J Edelman; Suzanne Ostrand-Rosenberg
Journal:  Cancer Immunol Immunother       Date:  2008-03-06       Impact factor: 6.968

10.  Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer.

Authors:  Srinivas Nagaraj; Kapil Gupta; Vladimir Pisarev; Leo Kinarsky; Simon Sherman; Loveleen Kang; Donna L Herber; Jonathan Schneck; Dmitry I Gabrilovich
Journal:  Nat Med       Date:  2007-07-01       Impact factor: 53.440

View more
  30 in total

1.  S100A9 maintains myeloid-derived suppressor cells in chronic sepsis by inducing miR-21 and miR-181b.

Authors:  Tuqa Alkhateeb; Ajinkya Kumbhare; Isatou Bah; Dima Youssef; Zhi Q Yao; Charles E McCall; Mohamed El Gazzar
Journal:  Mol Immunol       Date:  2019-05-09       Impact factor: 4.407

2.  Phenotypically resembling myeloid derived suppressor cells are increased in children with HIV and exposed/infected with Mycobacterium tuberculosis.

Authors:  Nelita Du Plessis; Ruschca Jacobs; Andrea Gutschmidt; Zhuo Fang; Paul D van Helden; Manfred B Lutz; Anneke C Hesseling; Gerhard Walzl
Journal:  Eur J Immunol       Date:  2016-12-16       Impact factor: 5.532

Review 3.  The RB tumor suppressor at the intersection of proliferation and immunity: relevance to disease immune evasion and immunotherapy.

Authors:  Jack Hutcheson; Agnieszka K Witkiewicz; Erik S Knudsen
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

4.  Expansion of myeloid-derived suppressor cells promotes differentiation of regulatory T cells in HIV-1+ individuals.

Authors:  Ling Wang; Juan Zhao; Jun P Ren; Xiao Y Wu; Zheng D Morrison; Mohamed A Elgazzar; Shun B Ning; Jonathan P Moorman; Zhi Q Yao
Journal:  AIDS       Date:  2016-06-19       Impact factor: 4.177

5.  NFI-A disrupts myeloid cell differentiation and maturation in septic mice.

Authors:  Clara McClure; Ekram Ali; Dima Youssef; Zhi Q Yao; Charles E McCall; Mohamed El Gazzar
Journal:  J Leukoc Biol       Date:  2015-08-10       Impact factor: 4.962

6.  Hepatitis C virus-induced myeloid-derived suppressor cells regulate T-cell differentiation and function via the signal transducer and activator of transcription 3 pathway.

Authors:  Jun P Ren; Juan Zhao; Jun Dai; Jeddidiah W D Griffin; Ling Wang; Xiao Y Wu; Zheng D Morrison; Guang Y Li; Mohamed El Gazzar; Shun B Ning; Jonathan P Moorman; Zhi Q Yao
Journal:  Immunology       Date:  2016-06-22       Impact factor: 7.397

7.  Interleukin-10 production by myeloid-derived suppressor cells contributes to bacterial persistence during Staphylococcus aureus orthopedic biofilm infection.

Authors:  Cortney E Heim; Debbie Vidlak; Tammy Kielian
Journal:  J Leukoc Biol       Date:  2015-07-31       Impact factor: 4.962

8.  AhR Activation Leads to Massive Mobilization of Myeloid-Derived Suppressor Cells with Immunosuppressive Activity through Regulation of CXCR2 and MicroRNA miR-150-5p and miR-543-3p That Target Anti-Inflammatory Genes.

Authors:  Wurood Hantoosh Neamah; Narendra P Singh; Hasan Alghetaa; Osama A Abdulla; Saurabh Chatterjee; Philip B Busbee; Mitzi Nagarkatti; Prakash Nagarkatti
Journal:  J Immunol       Date:  2019-09-06       Impact factor: 5.422

9.  Heterogeneity of Ly6G+ Ly6C+ Myeloid-Derived Suppressor Cell Infiltrates during Staphylococcus aureus Biofilm Infection.

Authors:  Cortney E Heim; Sean C West; Hesham Ali; Tammy Kielian
Journal:  Infect Immun       Date:  2018-11-20       Impact factor: 3.441

10.  Decline of miR-124 in myeloid cells promotes regulatory T-cell development in hepatitis C virus infection.

Authors:  Jun P Ren; Lin Wang; Juan Zhao; Ling Wang; Shun B Ning; Mohamed El Gazzar; Jonathan P Moorman; Zhi Q Yao
Journal:  Immunology       Date:  2016-11-11       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.